Tiotropium is a long-acting muscarinic antagonist (LAMA) indicated for the treatment of chronic obstructive pulmonary disease (COPD) patients
Tiotropium has a prolonged binding to M3 muscarinic receptors, which coupled to a faster dissociation from M2 muscarinic receptors for a prolonged duration of the bronchodilator effect.
Our innovative product contains 8.8µg of tiotropium as an inhalation powder in HMPC capsules to be used with our proprietary DPI device. Our approach greatly improves safety of the patient with an equivalent efficacy when compared to the originator product
Our product is supported with pharmacokinetic and pharmacodynamic clinical studies.